ReviewInternational journal of molecular sciences2023

Aducanumab-Hope or Disappointment for Alzheimer's Disease.

Karolina Wojtunik-Kulesza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.